Diligence memo · auto-generated · as of July 2, 2026
Drug Delivery Company, LLC
Drug Delivery Company, LLC looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Drug Delivery Company, LLC operates in Biotechnology, based in SALISBURY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Drug Delivery Company, LLC has raised $4.7M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.5M on 2022-06-28.
Most recent recorded round closed around 2024-08-12.
Valuation (modeled)modeled
Provath models Drug Delivery Company, LLC at approximately $3.1M (range $486K–$7.9M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.22× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 23 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 2.2× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 42% of Biotechnology peers (4293 compared).
Modeled value ranks above 7% of those peers.
Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.